A decrease in the OPG/RANKL ratio is involved in the development of post-menopausal or glucorticoid-induced OP, bone erosions of rheumatoid arthritis, and bone disease associated with malignant and non-malignant conditions [56]. Here, TNFRSF11B is linked to rheumatoid arthritis.